Tear test could spot eye disease risk in thyroid patients
NCT ID NCT07472062
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This research study aims to create a simple, non-invasive test using tears and blood to predict which patients with hyperthyroidism are at risk of developing Graves' Orbitopathy (eye disease). Researchers will analyze samples from 90 participants, including healthy controls and those with thyroid or eye conditions. The goal is to find biomarkers that allow for earlier, personalized care to prevent or reduce the severity of eye problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAVES ORBITOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ghent University Hospital
Ghent, 9000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a cholesterol drug shrink eye muscle swelling in thyroid eye disease?
- Can a pill reverse eye bulging in thyroid eye disease?
- Smart wristband may spot thyroid drug imbalances before blood tests do
- Foot flex could tame cholesterol and blood sugar
- New pill could help when steroids fail for bulging eyes
- Promising drug trial for thyroid eye disease halted early